FDA News

Featured Article
U.S. FDA Panel Split Over Approval of Durect's Non-Opioid Painkiller
Independent experts on an FDA advisory panel were recently split over the approval of a non-opioid painkiller to manage post-surgical pain.
Changing FDA Procedures May Mean Less Exacting Standards
Changes in FDA procedures meant to speed approvals for medications may have resulted in less exacting standards, a new analysis suggests.
Acne Medication Recalled
The FDA has issued a Class II recall for a prescription treatment used for patients with severe acne.

Newsfeed

U.S. FDA Panel Split Over Approval of Durect's Non-Opioid Painkiller
Changing FDA Procedures May Mean Less Exacting Standards
Acne Medication Recalled
Glaucoma Drug Recalled
More Antacid Recalls Announced
FDA Releases Enforcement Policy For Flavored E-Cigarettes
Seizure Med Recalled
Dementia Drug Recalled
View More
Back to Top